SCHEMBL30518612

SCHEMBL30518612

CCCCc1cc[n+](O)cc1.CCCCc1cc[n+]([O-])cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 2/20 0.43
▸ CA1 P00915 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ESR1 P03372 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ ADRA2A P08913 2/20 0.40
▸ ADORA3 P0DMS8 2/20 0.40
▸ TACR2 P21452 2/20 0.40
▸ SLC6A2 P23975 2/20 0.40
▸ SLC6A4 P31645 2/20 0.40
▸ SLC6A3 Q01959 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ SHBG P04278 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ HSPD1 P10809 1/20 0.40
▸ ADRB3 P13945 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6622409 0.90 CA2 (0.47) CA2CA1ALDH1A1HSD17B10HPGD
SCHEMBL4071544 0.84 CYP3A4 (0.50) CA2ALDH1A1HSD17B10ESR1CYP3A4
SCHEMBL9440297 0.82 ESR1 (0.53) CA2ALDH1A1HSD17B10ESR1CYP3A4
SCHEMBL10983126 0.82 ESR1 (0.53) CA2ALDH1A1HSD17B10ESR1CYP3A4
SCHEMBL8028115 0.82 ESR1 (0.53) CA2ALDH1A1HSD17B10ESR1CYP3A4
SCHEMBL24434488 0.78 LPL (0.46) CA2ALDH1A1HSD17B10ESR1CYP3A4
SCHEMBL6181011 0.78 CA2 (0.43) CA2ALDH1A1CYP3A4LMNAPLK1
SCHEMBL5292039 0.71 HTR2A (0.48) CA2CA1ALDH1A1HSD17B10HPGD
SCHEMBL13018525 0.70 MMP1 (0.34) CA2SMN1; SMN2CYP3A4GGPS1
SCHEMBL1434203 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116547282-A Heterocyclic compounds and their use for the treatment of helminth infections and diseases 新基公司 2023-08-04 — — CN disclosed
Send feedback